ライフサイエンスコーパス: infectious disease

1 tion in ChrY in regulating susceptibility to infectious disease.

2 mortality particularly because of cancer and infectious disease.

3 ms the public health response to this highly infectious disease.

4 riginally developed to prevent or ameliorate infectious disease.

5 monkeypox is considered an emerging zoonotic infectious disease.

6 he development of new therapeutic agents for infectious disease.

7 ith time, lead to increased vulnerability to infectious diseases.

8 this supplemental edition of the Journal of Infectious Diseases.

9 if we are to continue to successfully treat infectious diseases.

10 eases from cancer and autoimmune diseases to infectious diseases.

11 ure due to high mortalities mainly caused by infectious diseases.

12 s, including neurodegenerative disorders and infectious diseases.

13 ies for the diagnosis of a broad spectrum of infectious diseases.

14 nensis] and samples from patients with other infectious diseases.

15 the resolution of inflammation in lupus and infectious diseases.

16 icrobial communities and in the treatment of infectious diseases.

17 recently used as biomarkers for diagnosis of infectious diseases.

18 es, as well as in the progression of certain infectious diseases.

19 therapeutic potential against diverse severe infectious diseases.

20 are for patients with Ebola and other highly infectious diseases.

21 ram-positive bacteria remains a challenge in infectious diseases.

22 ble for the diagnosis of most autoimmune and infectious diseases.

23 a paradigm for preparing for future emerging infectious diseases.

24 ntapped compounds could be used for treating infectious diseases.

25 tion in one of the most clinically important infectious diseases.

26 receptor (S1PR) agonism in the treatment of infectious diseases.

27 s increasingly affecting the epidemiology of infectious diseases.

28 ted as promising agents in the fight against infectious diseases.

29 , opening new possibilities for treatment of infectious diseases.

30 kely to further advance our understanding of infectious diseases.

31 nwhite OTRs should focus on inflammatory and infectious diseases.

32 national surveillance system for notifiable infectious diseases.

33 or prevent treatment failures in cancer and infectious diseases.

34 nostics are a cornerstone of the practice of infectious diseases.

35 diagnosis and real-time tracking of emerging infectious diseases.

36 tion creates when monitoring and controlling infectious diseases.

37 evelopment blueprint initiative for emerging infectious diseases.

38 sporter may serve as therapeutic targets for infectious diseases.

39 n affect the transmission and persistence of infectious diseases.

40 es remain the most effective tool to prevent infectious diseases.

41 between individuals to prevent the spread of infectious diseases.

42 entially allowing prevention or treatment of infectious diseases.

43 such goal will affect the ability to control infectious diseases.

44 rgets for treating cancer, autoimmunity, and infectious diseases.

45 ut also offers adaptability to model similar infectious diseases.

46 ntal demands increase the risk of particular infectious diseases.

47 therefore increase susceptibility to diverse infectious diseases.

48 eed for improved diagnostics in the field of infectious diseases.

49 aid in the control of zoonotic and emerging infectious diseases.

50 endangered wildlife against a rising tide of infectious disease?

51 est rising primary noncardiac diagnoses were infectious diseases (7.8%-15.1%) and respiratory disease

52 ticularly beneficial in patients treated for infectious diseases (88-100%).

53 containing information on medically attended infectious diseases according to International Classific

54 Malaria is among the most serious infectious diseases affecting humans, accounting for app

55 vergent risk pattern in the risk of 4 common infectious diseases after bariatric surgery.

56 antially reduce morbidity and mortality from infectious diseases after birth.

57 stinct processes underlie protection against infectious diseases after natural infection with pathoge

58 onship of bariatric surgery with the risk of infectious diseases among obese adults.

59 lymphoma that was initially diagnosed as an infectious disease and chronic gastritis, based on clini

60 to improve the efficacy of vaccines against infectious disease and immunotherapies for cancer, autoi

61 equire ongoing commitments to eradication of infectious disease and increase the emphasis on chronic

62 forward through the morass of drug-resistant infectious disease and should be fully explored.

63 formed adaptations that reduce the impact of infectious disease and that are expected to maximize the

64 sed therapies and foster new applications in infectious diseases and autoimmunity.

65 countries, both because of the emergence of infectious diseases and because strains of pathogens tha

66 based compounds have been exploited to treat infectious diseases and cancer, with such chemicals ofte

67 ich are effective drugs for the treatment of infectious diseases and cancers.

68 eillance and apply it to severe neurological infectious diseases and fatal respiratory infectious dis

69 o the development of mitigation policies for infectious diseases and financial contagion in economic

70 ch has important implications for combatting infectious diseases and for stably establishing probioti

71 molecular mechanisms of disease, focusing on infectious diseases and host-pathogen interactions, canc

72 selected diseases, which included individual infectious diseases and individual neurologic, autoimmun

73 the most pressing challenges in the field of infectious diseases and is one of 4 key areas of unmet m

74 sociated biomarkers for other autoimmune and infectious diseases and lead to the exploration of promi

75 s are associated with susceptibility to many infectious diseases and may be determinants of clinical

76 rophages, is a first line of defense against infectious diseases and plays a key role triggering the

77 iatric and adult specialists in the field of infectious diseases and represented other organizations

78 on has aimed at optimizing the management of infectious diseases and surveying the local and global e

79 rs, a reverse trend between the frequency of infectious diseases and the incidence of autoimmune and

80 otential for deciphering immune responses to infectious diseases and to vaccines.

81 erty include, for instance, food insecurity, infectious disease, and psychological stress related to

82 ameterize transmission models of respiratory infectious diseases, and inform intervention strategies

83 contributes to both chronic inflammatory and infectious diseases, and may have protective or pathogen

84 ding strokes, trauma, inflammatory diseases, infectious diseases, and neurodegenerative diseases.

85 Basic sciences, microbiology, infectious diseases, and public health constitute an epi

86 lic consequences of poverty, high fertility, infectious diseases, and rapid changes in nutrition and

87 k towards new medicines to treat devastating infectious diseases, and use bacteria to understand the

88 contribution of the intestinal microbiota to infectious disease are discussed.

89 Infectious diseases are a leading cause of death globall

90 Infectious diseases are a major global health issue.

91 option for EBOV disease.IMPORTANCE Emerging infectious diseases are a major public health concern, a

92 ver, data on the pathogen-specific causes of infectious diseases are limited.

93 Infectious diseases are one of the most common threats f

94 ield of neurodegenerative, inflammatory, and infectious diseases as well as diabetes and cancer.

95 with great potential for nuclear imaging of infectious diseases, as its cationic-rich fragment TGRAK

96 t multiple National Institute of Allergy and Infectious Disease-assigned category A priority pathogen

97 r POC development is the ability to diagnose infectious diseases at sites with a limited infrastructu

98 tor of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health

99 al Ab levels critical for protection against infectious disease, autoimmunity, allergy, cancer, and a

100 andicap model, which posits that the greater infectious disease burden in males is due to testosteron

101 ons in tropical countries is needed, and the infectious disease burden in these countries is another

102 for centuries continue to cause most of the infectious disease burden.

103 lso may contribute to the sex differences in infectious disease burden.

104 f alleles conferring survival advantages for infectious diseases, but that are maladaptive in modern-

105 ubiquitous and affects the spatial spread of infectious diseases, but the ability to measure seasonal

106 stranded DNA (dsDNA) viruses associated with infectious diseases, but they are better known as tools

107 Reduced susceptibility to infectious disease can increase the frequency of otherwi

108 Effective reduction of the spread of infectious diseases can be achieved through collaboratio

109 tions characterized by inflammation, such as infectious disease, cancer, or autoimmunity.

110 ing significant progress in studies of human infectious disease, cancer, regenerative medicine, graft

111 ANCE Human monkeypox is an emerging zoonotic infectious disease caused by Monkeypox virus (MPXV).

112 Poliomyelitis is a highly infectious disease caused by poliovirus (PV).

113 Poliomyelitis is a highly infectious disease caused by PV and is on the verge of e

114 he physiological response of the organism to infectious diseases caused by organisms such as bacteria

115 losis (TB) remains one of the most prevalent infectious diseases causing morbidity and death in >1.5

116 Infectious diseases claim millions of lives every year,

117 e clinics, local health clinics, and private infectious disease clinics in 12 countries and one US te

118 3b study done in 86 hospital and university infectious disease clinics, local health clinics, and pr

119 as associated with a significant increase in infectious disease consultations at a quaternary care ch

120 We conclude that infectious disease could lead to increased uncertainty i

121 th differential presentation and homology to infectious disease-derived peptides identified long-term

122 igate and control outbreaks, detect emerging infectious diseases, develop vaccines, and combat antimi

123 successful strategies for the prevention of infectious diseases, development of vaccines for cancer

124 ntitative profiling applications, especially infectious disease diagnostics.

125 hip in the implementation of rapid molecular infectious disease diagnostics.

126 In contrast, infectious diseases diagnostics must contend with scores

127 ent, and execution is advancing the field of infectious diseases diagnostics.

128 surviving early hazards, like prematurity or infectious disease, does not guarantee that children's d

129 in Hong Kong which is a hotspot for emerging infectious diseases due to its high population density a

130 ed to improve the forecast accuracy of other infectious disease dynamical models.Inaccuracy of influe

131 setting (critical to our ability to project infectious disease dynamics from thermal relationships a

132 and valuable resource for understanding the infectious disease dynamics in wildlife.

133 shed light on linkages between behavior and infectious disease dynamics, providing insights for cons

134 After implementing infectious diseases e-consults within an electronically

135 Here we update a global database of emerging infectious disease (EID) events, create a novel measure

136 The approach used so far for emerging infectious diseases (EIDs) does not work from the techni

137 Emerging infectious diseases (EIDs) threaten the health of people

138 lobal climate change and increasing rates of infectious disease emergence are occurring simultaneousl

139 facilitate the testing of countermeasures in infectious disease emergencies.

140 rapid molecular diagnostic technologies for infectious diseases enable expedited accurate microbiolo

141 ich will affect the ecology and evolution of infectious disease epidemics.

142 rPH (1922-2007), was initially trained as an infectious disease epidemiologist at the Johns Hopkins S

143 impact of pathogen evolutionary dynamics on infectious disease epidemiology.

144 he role of the ErbB family in the context of infectious disease, exploring the mechanisms that govern

145 roups, the National Institute of Allergy and Infectious Diseases facilitated development of addendum

146 tive for point-of-care (POC) diagnostics for infectious disease, food safety, and many other medical

147 in a 2016 National Institutes of Allergy and Infectious Diseases-funded Technical Consultation focuse

148 The surveillance of infectious diseases has recently assumed greater importa

149 Historically, diagnosis of infectious diseases has relied on pathogen detection; ho

150 tance (MDR) and its association with serious infectious diseases, has increased at alarming rates.

151 Infectious diseases have a profound impact on our health

152 Throughout human evolution, infectious diseases have been a primary cause of death.

153 Emerging infectious diseases have risen to prominence due to thei

154 In the context of infectious diseases, however, less is known about the in

155 For many infectious diseases, however, there is pronounced season

156 become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly

157 An infectious disease (ID) consultation is often obtained t

158 The impact on patient survival of an infectious disease (ID) team dedicated to the early mana

159 Infectious diseases (ID) consultation and antimicrobial

160 The decline in applications for infectious diseases (ID) fellowships has been an area of

161 While a career in infectious diseases (ID) has always been challenging and

162 al infectious diseases and fatal respiratory infectious diseases in Bangladesh.

163 eferral center for high-risk pregnancies and infectious diseases in children in Rio de Janeiro, Brazi

164 t, were recruited at Toma Ciorba Hospital of Infectious Diseases in Chisinau, Moldova.

165 response to a biowarfare agent, treatment of infectious diseases in general could benefit tremendousl

166 tterns relevant to the spread of respiratory infectious diseases in Hong Kong which is a hotspot for

167 tterns relevant to the spread of respiratory infectious diseases in Hong Kong.

168 ation of pathogens, and increase exposure to infectious diseases in humans and wildlife.

169 About 60% of emerging infectious diseases in humans are of zoonotic origin.

170 Infectious diseases in livestock can be transmitted thro

171 ing a research hospital for the treatment of infectious diseases in Marseille.

172 ickly diagnose a multitude of autoimmune and infectious diseases in point-of-care settings.

173 m perfringens is one of the most detrimental infectious diseases in poultry.

174 rickettsii, is among the most lethal of all infectious diseases in the Americas.

175 Tuberculosis remains one of the deadliest infectious diseases in the world, and the increased numb

176 y for the simultaneous prevention of several infectious diseases in vulnerable populations.

177 list (gastroenterologist/hepatologist and/or infectious diseases) in the first year after cirrhosis d

178 Prediction of the growth and decline of infectious disease incidence has advanced considerably i

179 nal exposure during pregnancy and infancy on infectious disease incidence was evaluated using Poisson

180 sponses, yet their effects on the outcome of infectious diseases, including influenza A virus (IAV) i

181 lnutrition (PEM) increases susceptibility to infectious diseases, including influenza infection, but

182 from increased morbidity and mortality from infectious diseases, independent of immunosuppressive th

183 on 2 prior National Institute of Allergy and Infectious Diseases Inner City Asthma Consortium trials.

184 s crucial for public health as the threat of infectious disease is dramatically increasing globally d

185 n a variety of cancers, their involvement in infectious disease is less recognised.

186 The application of this technology to infectious diseases is far less developed.

187 ponse to common infections.Susceptibility to infectious diseases is, among others, influenced by the

188 ead or potential aerosol release of emerging infectious diseases, it will be critical to develop plat

189 nds critically on the natural history of the infectious disease, its inherent transmissibility, and t

190 Tuberculosis is the world's leading infectious disease killer.

191 We find that, for a mild infectious disease (low infection probability) on a temp

192 rtant step towards personalized medicine and infectious disease management.

193 istribution of antibody titers to an endemic infectious disease may include information on multiple s

194 eading to anemia, including malnutrition and infectious diseases, may also play a role in the develop

195 nephrology, surgery, immunology, pathology, infectious disease medicine, cardiology, and oncology.

196 bability of increased host susceptibility to infectious disease might increase, but the effect will d

197 By applying an environmentally mediated infectious disease model to the 1993 Milwaukee Cryptospo

198 Tighter integration of infectious disease models with public health practice an

199 Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, ye

200 SD increment: 1.47; 95% CI: 1.12, 1.95), and infectious disease mortality (HR per SD increment: 1.50;

201 ninfectious diseases, but a 43% reduction in infectious disease mortality rate (MRR, 0.57; 95% CI, .3

202 A university-based institute of infectious diseases must therefore not only gather excel

203 The National Institute of Allergy and Infectious Diseases; National Institute of Environmental

204 d from the National Institute of Allergy and Infectious Disease (NIAID) workshop 'Complex Systems Sci

205 ty for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes o

206 is a U.S. National Institute of Allergy and Infectious Diseases (NIAID)-sponsored Bioinformatics Res

207 emonstrate that obesity is a risk factor for infectious diseases, no study has investigated the relat

208 iven by greater reductions in mortality from infectious diseases, nutritional deficiencies and anaemi

209 could be beneficial in areas where multiple infectious diseases occur contemporaneously or in the ca

210 kinsea might represent the third most common infectious disease of anurans after ranavirus infections

211 respiratory disease (BRD) is the most common infectious disease of beef and dairy cattle and is chara

212 Our findings suggest that a severe infectious disease of tadpoles caused by a protist belon

213 nge the clinical management of patients with infectious diseases of bacterial origin.

214 g from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health

215 lth needs and better protect the public from infectious disease often motivates the transition.

216 ve chronic inflammation in the context of an infectious disease or cellular stress, and they trigger

217 and adoptive T cell therapies for cancer and infectious diseases or, conversely, how it could be disr

218 e thirty-one aminoacyl-tRNA synthetases from infectious disease organisms by co-crystallization in th

219 Inclusion body disease (IBD) is an infectious disease originally described in captive snake

220 Decisions surrounding how to control an infectious disease outbreak currently rely on a subjecti

221 Strategies for containing an emerging infectious disease outbreak must be nonpharmaceutical wh

222 The traits of the primary case of an infectious disease outbreak, and the circumstances for t

223 Recent infectious disease outbreaks have further highlighted th

224 fy the extent to which media interest during infectious disease outbreaks is indicative of trends of

225 valuated the method using data from multiple infectious disease outbreaks reported in the United Stat

226 he model to five datasets on densely sampled infectious disease outbreaks, covering a wide range of e

227 samples becomes more and more routine during infectious disease outbreaks.

228 anding the genetic underpinnings that affect infectious disease outcomes should allow tailored treatm

229 rmone-based contraceptives on the outcome of infectious diseases outside the reproductive tract is ra

230 % (considering healthy individuals and other infectious diseases patients).

231 factors can have a substantial influence on infectious disease patterns, altering density of pneumoc

232 Public health offers infectious disease physicians a variety of rewarding car

233 ng medical research, and enhancing access to infectious diseases physicians.

234 As infectious diseases pose a threat to host integrity, euk

235 l-being via its effects on climate-sensitive infectious diseases, potentially changing their spatial

236 he content and improve the accuracy of these infectious disease predictions.

237 acterium tuberculosis remains a major global infectious disease problem, and a more efficacious vacci

238 Real-time bioimaging of infectious disease processes may aid countermeasure deve

239 via medical equipment highlight the need for infectious disease professionals to understand that fomi

240 p programs support, and do not compete with, infectious disease programs.

241 We examined whether immunity and within-host infectious disease progression are altered in CBVs under

242 thermal effects on immunity and within-host infectious disease progression under controlled conditio

243 n have profound impacts on the occurrence of infectious diseases ranging from dengue to cholera.

244 Emerging infectious diseases rarely affect all members of a popul

245 ts to offer BLAST for eligible patients with infectious diseases receiving nonpreferred therapy due t

246 was primarily a result of reduced risks for infectious disease-related hospitalizations.

247 ggests potential implications for immune and infectious-disease-related outcomes.

248 r, a novel concept to improve diagnostics in infectious diseases relies instead on the detection of c

249 Infectious diseases represent one of the greatest potent

250 by Mycobacterium tuberculosis (Mtb), is the infectious disease responsible for the highest number of

251 ronments may not be able to reliably project infectious disease risk from thermal data alone.

252 early-life microbiota of hosts might affect infectious disease risk throughout life, if such disrupt

253 profiles in anthropogenic habitats to reduce infectious disease risks in provisioned populations.

254 National policies designed to control infectious diseases should allocate resources for interv

255 or point-of-care (POC) diagnosis of multiple infectious diseases simultaneously, especially in resour

256 tive introspection for the leadership of the Infectious Disease Society of America (IDSA).

257 We applied the American Thoracic Society/Infectious Disease Society of America criteria to differ

258 The Infectious Diseases Society of America (IDSA) guidelines

259 In 2016, the Infectious Diseases Society of America (IDSA) recommende

260 nded for common outpatient conditions in the Infectious Diseases Society of America Practice Guidelin

261 ters for Disease Control and Prevention, and Infectious Diseases Society of America searched, selecte

262 The Infectious Diseases Society of American considers adhere

263 o burn patients with a team that includes an infectious disease specialist and a pharmacist in additi

264 first time the influence of animal trade on infectious disease spread in the region.

265 Salmonella infectious diseases spreading every day through food hav

266 n the Seattle Structural Genomics Center for Infectious Disease (SSGCID) structure determination pipe

267 eeded to address established arthropod-borne infectious diseases such as dengue and yellow fever and

268 nt dual vaccines against rabies and emergent infectious diseases such as Ebola virus.

269 on detection, treatment, and eradication of infectious diseases such as tuberculosis, malaria, and h

270 e change in driving the spread of waterborne infectious diseases, such as those caused by bacterial p

271 tic and diagnostic biomarkers in many common infectious diseases, such as Tuberculosis (TB).

272 National Institute of Allergy and Infectious Diseases supported this analysis.

273 The German infectious disease surveillance system revealed an incre

274 for evaluating molecular devices for use in infectious disease testing.

275 Dengue is an important infectious disease that presents high incidence and yiel

276 d hope that new ways will be found to combat infectious diseases that have proven refractory to class

277 l group of experts in pediatric oncology and infectious diseases that includes a patient advocate.

278 ed how environmental degradation exacerbates infectious disease, the effects of human health on our u

279 anded to provide ongoing therapy for chronic infectious disease, there is a pressing need to meet the

280 Coronaviruses (CoVs) are a major infectious disease threat and include the pathogenic hum

281 health officials plan for the next emerging infectious disease threat.The last 18 months have witnes

282 that were learned that can be applied to the infectious disease threats that will inevitably be faced

283 terns has implications ranging from emerging infectious disease to managing host microbiomes.

284 antibiotic use was adjudicated by at least 2 infectious diseases-trained clinicians and according to

285 en shown to capture early reports of unknown infectious disease transmission prior to official labora

286 tochastic mathematical model was adapted for infectious disease transmission that estimated a distrib

287 red the most effective route of between-farm infectious disease transmission.

288 If the control of infectious diseases was the public health success story

289 Tuberculosis (TB) is a deadly infectious disease, which kills millions of people every

290 Emerging infectious diseases will continue to threaten public hea

291 er is a rare acute and multisystemic febrile infectious disease with a mortality rate of >/=50% witho

292 most bacterial meningitis, a serious global infectious disease with high fatality, especially in dev

293 nsidered rare, a number of recently emerging infectious diseases with load-dependent pathology have l

294 esitancy, which risks the resurgence of many infectious diseases with public health and economic cons

295 Numerous studies have reported sex bias in infectious diseases, with bias direction dependent on pa

296 es of filoviruses and other high containment infectious diseases without the infrastructure requireme

297 2008, the National Institute of Allergy and Infectious Diseases, working with other organizations an

298 odontitis, which is the sixth most prevalent infectious disease worldwide (2) , ensues from the actio

299 bal health problem and the 6(th) most common infectious disease worldwide.

300 possibility of the expansion of vector-borne infectious diseases worldwide.